FULC icon

Fulcrum Therapeutics

108 hedge funds and large institutions have $918M invested in Fulcrum Therapeutics in 2022 Q1 according to their latest regulatory filings, with 21 funds opening new positions, 29 increasing their positions, 38 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more funds holding in top 10

Funds holding in top 10:

more capital invested

Capital invested by funds: $ → $

more ownership

Funds ownership:

5% less first-time investments, than exits

New positions opened: 21 | Existing positions closed: 22

2% less funds holding

Funds holding: 110108 (-2)

24% less repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 38

Holders
108
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$5.89M
Puts
$1.56M
Net Calls
Net Calls Change

Top Sellers

1 -$15.3M
2 -$11.9M
3 -$9.18M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$7.21M
5
Two Sigma Advisers
Two Sigma Advisers
New York
-$6.94M
Name Holding Trade Value Shares
Change
Change in
Stake
101
$12K
102
$11.8K
103
$11K
104
$6K
105
$3K
106
$2K
107
$1K
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125